Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.

Identifieur interne : 001C84 ( PubMed/Checkpoint ); précédent : 001C83; suivant : 001C85

Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.

Auteurs : Sandra Zárate [Argentine] ; Gabriela Jaita ; Jimena Ferraris ; Guadalupe Eijo ; María L. Magri ; Daniel Pisera ; Adriana Seilicovich

Source :

RBID : pubmed:22844453

Descripteurs français

English descriptors

Abstract

Estrogens are key to anterior pituitary function, stimulating hormone release and controlling cell fate to achieve pituitary dynamic adaptation to changing physiological conditions. In addition to their classical mechanism of action through intracellular estrogen receptors (ERs), estrogens exert rapid actions via cell membrane-localized ERs (mERs). We previously showed that E2 exerts a rapid pro-apoptotic action in anterior pituitary cells, especially in lactotropes and somatotropes, through activation of mERs. In the present study, we examined the involvement of mERα in the rapid pro-apoptotic action of estradiol by TUNEL in primary cultures of anterior pituitary cells from ovariectomized rats using a cell-impermeable E2 conjugate (E2-BSA) and an ERα selective antagonist (MPP dihydrochloride). We studied mERα expression during the estrous cycle and its regulation by gonadal steroids in vivo by flow cytometry. We identified ERα variants in the plasma membrane of anterior pituitary cells during the estrous cycle and studied E2 regulation of these mERα variants in vitro by surface biotinylation and Western Blot. E2-BSA-induced apoptosis was abrogated by MPP in total anterior pituitary cells and lactotropes. In cycling rats, we detected a higher number of lactotropes and a lower number of somatotropes expressing mERα at proestrus than at diestrus. Acute E2 treatment increased the percentage of mERα-expressing lactotropes whereas it decreased the percentage of mERα-expressing somatotropes. We detected three mERα isoforms of 66, 39 and 22 kDa. Expression of mERα66 and mERα39 was higher at proestrus than at diestrus, and short-term E2 incubation increased expression of these two mERα variants. Our results indicate that the rapid apoptotic action exerted by E2 in lactotropes depends on mERα, probably full-length ERα and/or a 39 kDa ERα variant. Expression and activation of mERα variants in lactotropes could be one of the mechanisms through which E2 participates in anterior pituitary cell renewal during the estrous cycle.

DOI: 10.1371/journal.pone.0041299
PubMed: 22844453


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:22844453

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.</title>
<author>
<name sortKey="Zarate, Sandra" sort="Zarate, Sandra" uniqKey="Zarate S" first="Sandra" last="Zárate">Sandra Zárate</name>
<affiliation wicri:level="1">
<nlm:affiliation>Instituto de Investigaciones Biomédicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Instituto de Investigaciones Biomédicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jaita, Gabriela" sort="Jaita, Gabriela" uniqKey="Jaita G" first="Gabriela" last="Jaita">Gabriela Jaita</name>
</author>
<author>
<name sortKey="Ferraris, Jimena" sort="Ferraris, Jimena" uniqKey="Ferraris J" first="Jimena" last="Ferraris">Jimena Ferraris</name>
</author>
<author>
<name sortKey="Eijo, Guadalupe" sort="Eijo, Guadalupe" uniqKey="Eijo G" first="Guadalupe" last="Eijo">Guadalupe Eijo</name>
</author>
<author>
<name sortKey="Magri, Maria L" sort="Magri, Maria L" uniqKey="Magri M" first="María L" last="Magri">María L. Magri</name>
</author>
<author>
<name sortKey="Pisera, Daniel" sort="Pisera, Daniel" uniqKey="Pisera D" first="Daniel" last="Pisera">Daniel Pisera</name>
</author>
<author>
<name sortKey="Seilicovich, Adriana" sort="Seilicovich, Adriana" uniqKey="Seilicovich A" first="Adriana" last="Seilicovich">Adriana Seilicovich</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="RBID">pubmed:22844453</idno>
<idno type="pmid">22844453</idno>
<idno type="doi">10.1371/journal.pone.0041299</idno>
<idno type="wicri:Area/PubMed/Corpus">001D61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D61</idno>
<idno type="wicri:Area/PubMed/Curation">001D61</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D61</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C84</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C84</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.</title>
<author>
<name sortKey="Zarate, Sandra" sort="Zarate, Sandra" uniqKey="Zarate S" first="Sandra" last="Zárate">Sandra Zárate</name>
<affiliation wicri:level="1">
<nlm:affiliation>Instituto de Investigaciones Biomédicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</nlm:affiliation>
<country xml:lang="fr">Argentine</country>
<wicri:regionArea>Instituto de Investigaciones Biomédicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires</wicri:regionArea>
<wicri:noRegion>Buenos Aires</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jaita, Gabriela" sort="Jaita, Gabriela" uniqKey="Jaita G" first="Gabriela" last="Jaita">Gabriela Jaita</name>
</author>
<author>
<name sortKey="Ferraris, Jimena" sort="Ferraris, Jimena" uniqKey="Ferraris J" first="Jimena" last="Ferraris">Jimena Ferraris</name>
</author>
<author>
<name sortKey="Eijo, Guadalupe" sort="Eijo, Guadalupe" uniqKey="Eijo G" first="Guadalupe" last="Eijo">Guadalupe Eijo</name>
</author>
<author>
<name sortKey="Magri, Maria L" sort="Magri, Maria L" uniqKey="Magri M" first="María L" last="Magri">María L. Magri</name>
</author>
<author>
<name sortKey="Pisera, Daniel" sort="Pisera, Daniel" uniqKey="Pisera D" first="Daniel" last="Pisera">Daniel Pisera</name>
</author>
<author>
<name sortKey="Seilicovich, Adriana" sort="Seilicovich, Adriana" uniqKey="Seilicovich A" first="Adriana" last="Seilicovich">Adriana Seilicovich</name>
</author>
</analytic>
<series>
<title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint>
<date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Apoptosis (drug effects)</term>
<term>Cell Membrane (drug effects)</term>
<term>Cell Membrane (metabolism)</term>
<term>Estradiol (pharmacology)</term>
<term>Estrogen Receptor alpha (metabolism)</term>
<term>Estrogens (pharmacology)</term>
<term>Estrous Cycle (drug effects)</term>
<term>Female</term>
<term>Gene Expression Regulation (drug effects)</term>
<term>Lactotrophs (cytology)</term>
<term>Lactotrophs (drug effects)</term>
<term>Lactotrophs (metabolism)</term>
<term>Rats</term>
<term>Rats, Wistar</term>
<term>Somatotrophs (cytology)</term>
<term>Somatotrophs (drug effects)</term>
<term>Somatotrophs (metabolism)</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Apoptose ()</term>
<term>Cellules lactotropes ()</term>
<term>Cellules lactotropes (cytologie)</term>
<term>Cellules lactotropes (métabolisme)</term>
<term>Cellules somatotropes ()</term>
<term>Cellules somatotropes (cytologie)</term>
<term>Cellules somatotropes (métabolisme)</term>
<term>Cycle oestral ()</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Membrane cellulaire ()</term>
<term>Membrane cellulaire (métabolisme)</term>
<term>Oestradiol (pharmacologie)</term>
<term>Oestrogènes (pharmacologie)</term>
<term>Rat Wistar</term>
<term>Rats</term>
<term>Récepteur alpha des oestrogènes (métabolisme)</term>
<term>Régulation de l'expression des gènes ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Estrogen Receptor alpha</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Estradiol</term>
<term>Estrogens</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Cellules lactotropes</term>
<term>Cellules somatotropes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Lactotrophs</term>
<term>Somatotrophs</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Apoptosis</term>
<term>Cell Membrane</term>
<term>Estrous Cycle</term>
<term>Gene Expression Regulation</term>
<term>Lactotrophs</term>
<term>Somatotrophs</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Cell Membrane</term>
<term>Lactotrophs</term>
<term>Somatotrophs</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cellules lactotropes</term>
<term>Cellules somatotropes</term>
<term>Membrane cellulaire</term>
<term>Récepteur alpha des oestrogènes</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Oestradiol</term>
<term>Oestrogènes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Female</term>
<term>Rats</term>
<term>Rats, Wistar</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Apoptose</term>
<term>Cellules lactotropes</term>
<term>Cellules somatotropes</term>
<term>Cycle oestral</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Membrane cellulaire</term>
<term>Rat Wistar</term>
<term>Rats</term>
<term>Régulation de l'expression des gènes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Estrogens are key to anterior pituitary function, stimulating hormone release and controlling cell fate to achieve pituitary dynamic adaptation to changing physiological conditions. In addition to their classical mechanism of action through intracellular estrogen receptors (ERs), estrogens exert rapid actions via cell membrane-localized ERs (mERs). We previously showed that E2 exerts a rapid pro-apoptotic action in anterior pituitary cells, especially in lactotropes and somatotropes, through activation of mERs. In the present study, we examined the involvement of mERα in the rapid pro-apoptotic action of estradiol by TUNEL in primary cultures of anterior pituitary cells from ovariectomized rats using a cell-impermeable E2 conjugate (E2-BSA) and an ERα selective antagonist (MPP dihydrochloride). We studied mERα expression during the estrous cycle and its regulation by gonadal steroids in vivo by flow cytometry. We identified ERα variants in the plasma membrane of anterior pituitary cells during the estrous cycle and studied E2 regulation of these mERα variants in vitro by surface biotinylation and Western Blot. E2-BSA-induced apoptosis was abrogated by MPP in total anterior pituitary cells and lactotropes. In cycling rats, we detected a higher number of lactotropes and a lower number of somatotropes expressing mERα at proestrus than at diestrus. Acute E2 treatment increased the percentage of mERα-expressing lactotropes whereas it decreased the percentage of mERα-expressing somatotropes. We detected three mERα isoforms of 66, 39 and 22 kDa. Expression of mERα66 and mERα39 was higher at proestrus than at diestrus, and short-term E2 incubation increased expression of these two mERα variants. Our results indicate that the rapid apoptotic action exerted by E2 in lactotropes depends on mERα, probably full-length ERα and/or a 39 kDa ERα variant. Expression and activation of mERα variants in lactotropes could be one of the mechanisms through which E2 participates in anterior pituitary cell renewal during the estrous cycle.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">22844453</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>11</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<Issue>7</Issue>
<PubDate>
<Year>2012</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.</ArticleTitle>
<Pagination>
<MedlinePgn>e41299</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0041299</ELocationID>
<Abstract>
<AbstractText>Estrogens are key to anterior pituitary function, stimulating hormone release and controlling cell fate to achieve pituitary dynamic adaptation to changing physiological conditions. In addition to their classical mechanism of action through intracellular estrogen receptors (ERs), estrogens exert rapid actions via cell membrane-localized ERs (mERs). We previously showed that E2 exerts a rapid pro-apoptotic action in anterior pituitary cells, especially in lactotropes and somatotropes, through activation of mERs. In the present study, we examined the involvement of mERα in the rapid pro-apoptotic action of estradiol by TUNEL in primary cultures of anterior pituitary cells from ovariectomized rats using a cell-impermeable E2 conjugate (E2-BSA) and an ERα selective antagonist (MPP dihydrochloride). We studied mERα expression during the estrous cycle and its regulation by gonadal steroids in vivo by flow cytometry. We identified ERα variants in the plasma membrane of anterior pituitary cells during the estrous cycle and studied E2 regulation of these mERα variants in vitro by surface biotinylation and Western Blot. E2-BSA-induced apoptosis was abrogated by MPP in total anterior pituitary cells and lactotropes. In cycling rats, we detected a higher number of lactotropes and a lower number of somatotropes expressing mERα at proestrus than at diestrus. Acute E2 treatment increased the percentage of mERα-expressing lactotropes whereas it decreased the percentage of mERα-expressing somatotropes. We detected three mERα isoforms of 66, 39 and 22 kDa. Expression of mERα66 and mERα39 was higher at proestrus than at diestrus, and short-term E2 incubation increased expression of these two mERα variants. Our results indicate that the rapid apoptotic action exerted by E2 in lactotropes depends on mERα, probably full-length ERα and/or a 39 kDa ERα variant. Expression and activation of mERα variants in lactotropes could be one of the mechanisms through which E2 participates in anterior pituitary cell renewal during the estrous cycle.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zárate</LastName>
<ForeName>Sandra</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Instituto de Investigaciones Biomédicas, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jaita</LastName>
<ForeName>Gabriela</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ferraris</LastName>
<ForeName>Jimena</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Eijo</LastName>
<ForeName>Guadalupe</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Magri</LastName>
<ForeName>María L</ForeName>
<Initials>ML</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pisera</LastName>
<ForeName>Daniel</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Seilicovich</LastName>
<ForeName>Adriana</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>07</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047628">Estrogen Receptor alpha</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004967">Estrogens</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4TI98Z838E</RegistryNumber>
<NameOfSubstance UI="D004958">Estradiol</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047628" MajorTopicYN="N">Estrogen Receptor alpha</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004967" MajorTopicYN="N">Estrogens</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D030762" MajorTopicYN="N">Estrous Cycle</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052682" MajorTopicYN="N">Lactotrophs</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D052683" MajorTopicYN="N">Somatotrophs</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>05</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>06</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>7</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>7</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>12</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22844453</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0041299</ArticleId>
<ArticleId IdType="pii">PONE-D-12-12505</ArticleId>
<ArticleId IdType="pmc">PMC3402499</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2012 May 1;302(10):E1189-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22354782</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FASEB J. 2000 Jan;14(1):157-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10627290</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocrinology. 2002 Jul;143(7):2750-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12072410</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2005 Feb;288(2):E388-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15494610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurosci. 2002 Oct 1;22(19):8391-401</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12351713</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Endocrinol. 1993 May;93(1):47-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8319833</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Vis Exp. 2009 Dec 23;(34):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20032927</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bone. 2004 Jan;34(1):100-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14751567</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocrinology. 1998 Sep;139(9):3976-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9724053</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Biol Cell. 2005 Jan;16(1):231-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15496458</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Invest. 2003 Dec;112(11):1603-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14660734</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4807-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12682286</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocrine. 2011 Feb;39(1):21-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21069582</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Neuroendocrinology. 1996 Jun;63(6):530-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8793895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Endocrinol. 2000 Oct;14(10):1649-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11043579</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Neuroscience. 2008 Jul 17;154(4):1173-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18556135</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Endocrinol Metab. 2012 Jun;23(6):261-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22436593</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Tumour Biol. 1993;14(1):59-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8493452</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurosci. 2006 May 24;26(21):5649-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16723521</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>FASEB J. 2008 Sep;22(9):3328-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18541692</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9063-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16754886</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Oncogene. 2001 Sep 6;20(39):5420-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11571639</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Neuroendocrinology. 2009;90(3):292-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19684383</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Endocrinol. 2001 Dec;15(12):2064-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11731609</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Endocrinol. 1999 Feb;13(2):307-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9973260</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Gen Comp Endocrinol. 2008 Feb 1;155(3):857-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18067893</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Anal Biochem. 2010 Jun 15;401(2):318-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20206115</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurosci. 2010 Sep 22;30(38):12589-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20861365</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Endocrinol. 2012 May 15;355(1):169-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22366173</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Horm Res. 2010;38:25-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20616492</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocrinology. 2002 Mar;143(3):941-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11861516</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biol Reprod. 1988 Dec;39(5):1067-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3219380</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Breast Cancer Res. 2009;11(3):206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19519952</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocr Rev. 2008 Feb;29(1):1-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18057139</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Biol Chem. 2007 Aug 3;282(31):22278-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17535799</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocrinology. 2011 Dec;152(12):4789-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21952249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Breast Cancer Res. 2005;7(1):R130-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15642162</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Oncol. 2009 Jul 20;27(21):3423-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19487384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocrinology. 1992 Sep;131(3):1503-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1505480</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biol Reprod. 2011 Oct;85(4):770-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21734267</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Endocrinol. 2008 Sep;22(9):2116-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18617595</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E767-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15172886</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurochem. 2008 Aug;106(4):1525-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18489713</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Physiol Biochem. 2002 Apr;110(1-2):42-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11935399</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Endocrinology. 2005 Feb;146(2):736-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15528300</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurosci. 2007 Feb 21;27(8):2102-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17314305</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Endocrinol Metab. 2009 Dec;20(10):477-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19783454</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Physiol. 2002 Mar 1;539(Pt 2):557-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11882687</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Biochem Cell Biol. 2006 Mar;38(3):376-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16263324</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Endocrinol. 2010 Apr;205(1):49-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20139144</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neurosci. 2009 Dec 2;29(48):15323-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19955385</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Endocrinol Metab. 2000 Jul;11(5):168-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10856917</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21878-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21098290</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Front Horm Res. 2006;35:32-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16809921</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Neuroendocrinology. 2002 Nov;76(5):272-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12457038</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Environ Health. 2010 Oct 15;9:61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20950447</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Cell Endocrinol. 2008 Aug 13;290(1-2):24-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18534740</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cancer Lett. 2010 Feb 28;288(2):133-48</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19608332</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Steroids. 2008 May;73(5):515-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18289621</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mol Biol Cell. 2011 Nov;22(22):4415-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21937726</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Steroids. 2002 May;67(6):429-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11960618</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E664-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19158323</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Neuroendocrinol. 2002 Feb;14(2):85-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11849367</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Argentine</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Eijo, Guadalupe" sort="Eijo, Guadalupe" uniqKey="Eijo G" first="Guadalupe" last="Eijo">Guadalupe Eijo</name>
<name sortKey="Ferraris, Jimena" sort="Ferraris, Jimena" uniqKey="Ferraris J" first="Jimena" last="Ferraris">Jimena Ferraris</name>
<name sortKey="Jaita, Gabriela" sort="Jaita, Gabriela" uniqKey="Jaita G" first="Gabriela" last="Jaita">Gabriela Jaita</name>
<name sortKey="Magri, Maria L" sort="Magri, Maria L" uniqKey="Magri M" first="María L" last="Magri">María L. Magri</name>
<name sortKey="Pisera, Daniel" sort="Pisera, Daniel" uniqKey="Pisera D" first="Daniel" last="Pisera">Daniel Pisera</name>
<name sortKey="Seilicovich, Adriana" sort="Seilicovich, Adriana" uniqKey="Seilicovich A" first="Adriana" last="Seilicovich">Adriana Seilicovich</name>
</noCountry>
<country name="Argentine">
<noRegion>
<name sortKey="Zarate, Sandra" sort="Zarate, Sandra" uniqKey="Zarate S" first="Sandra" last="Zárate">Sandra Zárate</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C84 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C84 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:22844453
   |texte=   Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:22844453" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021